v3.26.1
Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Feb. 12, 2026
Dec. 31, 2025
Assumed Liabilities:      
Goodwill $ 596,029   $ 83,027
Avadel Pharmaceuticals Plc      
Acquired Assets:      
Cash and cash equivalents   $ 114,135  
Receivables   50,389  
Inventory   147,323  
Prepaid expenses and other current assets   13,483  
Property, plant and equipment   796  
Right-of-use assets   2,297  
Intangible assets   1,794,900  
Deferred tax assets 1,200 1,244  
Other assets   6,551  
Total fair value of assets acquired   2,131,118  
Assumed Liabilities:      
Accounts payable and accrued expenses   124,654  
Accrued sales discounts, allowances and reserves   24,969  
Operating lease liabilities   2,296  
Deferred tax liability $ 183,100 183,129  
Other long-term liabilities   2,152  
Total recognized identifiable net assets acquired and liabilities assumed   1,793,918  
Goodwill   513,002  
Preliminary fair value of total consideration   2,306,920  
Contingent consideration   107,713  
Total Cash Consideration Paid   $ 2,199,207